Sanofi Contingent Value Rights
GCVRZ
GCVRZ was delisted on the 3rd of March, 2020.
115 hedge funds and large institutions have $57M invested in Sanofi Contingent Value Rights in 2017 Q2 according to their latest regulatory filings, with 11 funds opening new positions, 20 increasing their positions, 12 reducing their positions, and 7 closing their positions.
67% more repeat investments, than reductions
Existing positions increased: 20 | Existing positions reduced: 12
57% more first-time investments, than exits
New positions opened: 11 | Existing positions closed: 7
4% more funds holding
Funds holding: 111 → 115 (+4)
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
15% less capital invested
Capital invested by funds: $67.2M → $57M (-$10.1M)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
SCM
Stonehill Capital Management
New York
|
+$2.55M |
| 2 |
HCM
Highbridge Capital Management
New York
|
+$229K |
| 3 |
SAM
Silverback Asset Management
Chapel Hill,
North Carolina
|
+$184K |
| 4 |
PAAMCP
Pacific Alternative Asset Management Company (PAAMCO)
Irvine,
California
|
+$112K |
| 5 |
AFM
Anson Funds Management
Dallas,
Texas
|
+$108K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
PC
PointState Capital
New York
|
-$3.29M |
| 2 |
RL
Ruffer LLP
London,
United Kingdom
|
-$6K |
| 3 |
FHA
Flagship Harbor Advisors
Boston,
Massachusetts
|
-$5.31K |
| 4 |
UBS Group
Zurich,
Switzerland
|
-$1.01K |
| 5 |
BWM
Baystate Wealth Management
Boston,
Massachusetts
|
-$1K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
DADC
76
D.A. Davidson & Co
Great Falls,
Montana
| – | -$82 | -200 | -22% |
|
|
WT
77
Whittier Trust
South Pasadena,
California
| – | -$78 | -191 | -18% |
|
|
BWM
78
Baystate Wealth Management
Boston,
Massachusetts
| – | -$1K | -40 | Closed |
|
|
EWM
79
Edge Wealth Management
New York
| – | -$1K | -34 | Closed |
|
80
Carson Wealth (CWM LLC)
Omaha,
Nebraska
| – | +$6 | +14 | New |
|
|
OIA
81
OneDigital Investment Advisors
Overland Park,
Kansas
| – | +$6 | +14 | New |
|
82
US Bancorp
Minneapolis,
Minnesota
| – | +$6 | +14 | +1% |
|
83
Lazard Asset Management
New York
| – | +$11 | +28 | New |
|
|
VWA
84
V Wealth Advisors
Overland Park,
Kansas
| – | +$12 | +29 | New |
|
|
CT
85
Clearstead Trust
Portland,
Maine
| – | +$41 | +100 | New |
|
|
NFG
86
Next Financial Group
Houston,
Texas
| – | +$41 | +100 | New |
|
|
SPIA
87
Steward Partners Investment Advisory
New York
| – | +$41 | +100 | +10,000% |
|
|
EDRH
88
Edmond de Rothschild Holding
Chambesy,
Switzerland
| – | +$408 | +1,000 | New |
|
|
SIC
89
Salem Investment Counselors
Winston Salem,
North Carolina
| – | +$408 | +1,000 | New |
|
GCVRZ Hedge Fund Activity: Q2 2017 in Review
115 of the 4,011 institutional investors tracked by Wall St. Rank reported a position in Sanofi Contingent Value Rights (GCVRZ) for Q2 2017, worth a combined $57M — down 15% from $67.2M a quarter earlier.
Buyers outnumbered sellers: 11 funds opened new GCVRZ positions and 7 closed out — a net gain of 4 holders — while 20 added to existing stakes and 12 trimmed.
The largest buyer was Stonehill Capital Management, adding an estimated $2.55M. The largest seller was PointState Capital, exiting entirely with an estimated $3.29M sold.
- 115 institutional investors held Sanofi Contingent Value Rights (GCVRZ) as of Q2 2017, up from 111 in Q1 2017.
- Funds reported $57M of Sanofi Contingent Value Rights stock for Q2 2017, down 15% quarter-over-quarter.
- 11 funds opened new Sanofi Contingent Value Rights positions in Q2 2017 and 7 closed out, a net change of +4 holders.
- The largest Sanofi Contingent Value Rights buyer in Q2 2017 was Stonehill Capital Management, an estimated $2.55M added.
- The largest Sanofi Contingent Value Rights seller in Q2 2017 was PointState Capital, an estimated $3.29M sold.
Based on aggregated 13F filings for Q2 2017.